Mksap 17 Infectious Disease

Understanding the ID Section in MKSAP 17

MKSAP 17 covers infectious diseases across its major organ system sections and standalone ID questions. The material assumes you are comfortable with empiric therapy decisions, not just rote memorization of bugs and drugs. I spent three weeks working through the ID questions before my last in-training exam, and what I noticed was that the questions are designed to make you pause and reconsider your first instinct more than once. The ID portion does not ask you to identify an organism in isolation. It asks you to manage a patient. You get a clinical scenario, sometimes with subtle details that change the answer entirely. I remember one question where the key was not the fever pattern but the fact that the patient had a recent hospitalization for pneumonia and was now presenting with a different infection. The answer pointed toward healthcare-associated pathogens, even though the vignette did not explicitly say "hospital-acquired." The questions follow a pattern that rewards clinical reasoning over flashcard recall. They test whether you know when to broaden coverage, when to narrow it, and when the best answer is actually no antibiotic at all. That last point comes up more often than most residents expect.

Key Topics You Will Encounter

Community-Acquired Pneumonia

The 2019 ATS/IDSA CAP guidelines changed the recommendations for outpatient treatment. MKSAP 17 reflects this. Amoxicillin alone is now preferred for previously healthy patients without comorbidities or risk factors for resistance. The older pattern of prescribing a macrolide to everyone is gone. If the question includes diabetes, chronic heart disease, or renal insufficiency, the answer shifts to a respiratory fluoroquinolone or beta-lactam plus macrolide. I still catch myself reaching for azithromycin on practice questions before I remember to look for those comorbidities first. VAP and HAP questions are where the scoring gets tricky. The timing matters. Early-onset VAP, before day four, often responds to narrower agents. Late-onset VAP after day four or with risk factors for MDR pathogens demands broader coverage, typically including an antipseudomonal beta-lactam. The IDSA guidelines for HAP-VAP updated the definitions of risk factors, and MKSAP 17 follows the later version. MRSA coverage with vancomycin or linezolid is recommended only when there is confirmed colonization or local epidemiology supports it. Empiric MRSA coverage without those indicators is one of the distractors they like to plant. Abscess management is straightforward in real life and in the questions: incision and drainage first. Antibiotics come second and are reserved for specific situations. The MKSAP questions test whether you know when antibiotics are actually indicated. Purulent cellulitis with systemic signs, immunocompromise, or rapidly progressive infection are the triggers. Simple abscess without those features does not need oral antibiotics after source control. I lost points on a practice block because I selected TMP-SMX for a patient who clearly just needed a procedure.

This is a high-yield topic and the algorithm is well established. Any temperature of 38.3 C or higher in a neutropenic patient requires immediate empiric antipseudomonal coverage. Cefepime, meropenem, or piperacillin-tazobactam are acceptable choices. The addition of vancomycin is not routine. It is reserved for hemodynamic instability, documented Gram-positive infection, catheter-related suspicion, or skin flora concerns. The questions like to add a central line and then see if you will jump to vancomycin without other indications. I learned that the hard way during a simulation exercise before my exam. The first mistake I kept making was overthinking the organism identification. The questions rarely ask "what is the bug." They ask "what do you do next." The answer is often a management decision, not a diagnosis. Another mistake was missing the duration component. Many ID questions include an option that looks correct but has the wrong length of therapy. A urinary tract infection with a fluoroquinolone might be 7 days, not 10, depending on the patient population. Those small details matter more than you think. I also fell for the trap of choosing the broadest antibiotic when the question implied a mild infection. The correct answer was sometimes the narrowest effective agent. The guidelines push for de-escalation, and the exam follows that same principle. If the culture results are back and you know the pathogen, narrowing is almost always the right move unless there is a specific reason to maintain broad coverage.

How to Use This Resource Effectively

Do not read the text passively. Work through the questions first, then review the explanations. The explanations in MKSAP 17 are where most of the learning happens. They cite the actual guideline references and explain why the wrong answers are wrong, which is just as important as knowing the right choice. I found myself returning to the same explanations multiple times because my reasoning was flawed even when I picked the correct answer by accident. The ID section also cross-references other specialties. You will see HIV questions embedded in the general ID content, transplant questions appearing in the immunosuppressed section, and neurosyphilis showing up in the infectious disease discussions alongside non-STD presentations. Pay attention to those connections. The exam does not compartmentalize diseases the way textbooks sometimes do.

Limitations of MKSAP 17 for ID Preparation

It is worth noting that MKSAP 17 is not the most current edition. Some guideline updates after its publication are not reflected in the text. Antimicrobial resistance patterns have shifted in many institutions, and the epidemiology described in the questions may not match your local hospital. Use MKSAP 17 as a foundation for clinical reasoning, but verify specific treatment protocols against your institution's antibiogram and the latest IDSA guidelines before relying on them in practice. The question logic is sound, but the reference dates matter when you are applying this to real patients. For anyone preparing for board exams or in-training assessments, the ID section is one of the areas where consistent practice pays the highest return. The material is not extremely long, but the questions require you to think like a clinician rather than a microbiologist. That shift in perspective is what separates a passing score from a strong one.